FDA Approves Wegovy as First Oral Weight-Loss Pill
TL;DR Summary
The FDA has approved the first daily oral medication version of Wegovy, a popular weight-loss drug, giving Novo Nordisk an advantage over Eli Lilly, whose similar drug is still under review. The pill, containing semaglutide, has shown significant weight loss in clinical trials and is expected to be available soon, potentially expanding access and reducing costs for obesity treatments.
- FDA approves Wegovy pill for weight loss, the first daily oral medication of its kind CBS News
- F.D.A. Approves Wegovy Weight-Loss Pill The New York Times
- Novo Nordisk stock surges on hopes Wegovy pill approval will deliver some 'redemption' for investors CNBC
- With FDA approval of Wegovy pill, new era of oral GLP-1 weight loss drugs begins CNN
- The Weight-Loss Drug Wegovy Now Comes in a Pill Time Magazine
Reading Insights
Total Reads
0
Unique Readers
2
Time Saved
4 min
vs 4 min read
Condensed
93%
799 → 59 words
Want the full story? Read the original article
Read on CBS News